Evidence map›Paper›PMID 39540773›Full record

ArticleJournal of clinical microbiology2024

Evaluation of the KPC/IMP/NDM/VIM/OXA-48 Combo Test Kit and Carbapenem-Resistant K.N.I.V.O. Detection K-Set in detecting KPC variants.

Aline Valério de Lima, Keila de Oliveira Lima, Paola Cappellano, Sebastian Cifuentes, Nilton Lincopan, Suely Carlos Ferreira Sampaio, Jorge Luiz Mello Sampaio

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Molecular Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aline Valério de LimaRAMC Laboratory-Antimicrobial Resistance and Clinical Microbiology, Department of Clinical Analysis and Toxicology, Faculty of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil.
Keila de Oliveira LimaRAMC Laboratory-Antimicrobial Resistance and Clinical Microbiology, Department of Clinical Analysis and Toxicology, Faculty of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil.
Paola CappellanoFleury Group, Microbiology Section, São Paulo, Brazil.
Sebastian CifuentesCentro de Referencia y Diagnóstico Médico, Osorno, Chile.
Nilton LincopanDepartment of Clinical Analysis and Toxicology, Faculty of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0003-0161-5800
Suely Carlos Ferreira SampaioFaculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.
Jorge Luiz Mello SampaioRAMC Laboratory-Antimicrobial Resistance and Clinical Microbiology, Department of Clinical Analysis and Toxicology, Faculty of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0001-7789-3028

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

carbapenemaseKPClateral flow immunoassayLFIA

Identifiers

PMID39540773
PMCPMC11633187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.